With the analysis among 5,613 patents, we discovered top 464 key players by total patent application. AstraZeneca Pharmaceutical Co., Ltd., Boehringer Ingelheim International GmbH, CHIESI Farmaceutici SpA are dominant in this area. They take 7.36% of the total patent filing.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 159
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 129
Emilia-Romagna, Italy
Patent: 125
F. Hoffmann-La Roche Ltd.
Theravance Biopharma R&D IP LLC
California, United States
Patent: 75
Biosplice Therapeutics, Inc.
California, United States
Patent: 59
California, United States
Patent: 53
New Jersey, United States
Patent: 50
Basel-Stadt, Switzerland
Patent: 49
With the analysis among 152 patents, we discovered top 31 start-ups by total patent application. Biosplice Therapeutics, Inc., Institut National de la Santé et de la Recherche Médicale, Metriopharm AG are active in this area.
Biosplice Therapeutics, Inc.
California, United States
Patent: 59
Institut National de la Santé et de la Recherche Médicale
ZURICH, Switzerland
Patent: 11
Cellular Approaches, Inc.
California, United States
Patent: 6
Galvanize Therapeutics, Inc.
California, United States
Patent: 5
California, United States
Patent: 4
With the analysis among related 717 patents applied in the last 5 years. We discover 323 most active companies in this area. The fast-growing CHIESI Farmaceutici SpA, Unity Biotechnology, Inc., Biosplice Therapeutics, Inc. take 10.74% of patent filing during this period.
Emilia-Romagna, Italy
Patent: 40
Unity Biotechnology, Inc.
California, United States
Patent: 26
Biosplice Therapeutics, Inc.
California, United States
Patent: 11
ZURICH, Switzerland
Patent: 11
The Board of Regents of The University of Texas System
Texas, United States
Patent: 9
Jiangsu Sheng, China
Patent: 8
Regents of the University of Colorado
Colorado, United States
Patent: 7
University of Ulsan Foundation for Industry Cooperation
Taiwan Liposome Co., Ltd.
Taiwan Province, China
Patent: 6
With the analysis among related 717 patents in last 5 years, we discover 195 new entrants. Metriopharm AG, Taiwan Liposome Co., Ltd., Vicore Pharma AB are the most active new entrants in this area.
ZURICH, Switzerland
Patent: 11
Taiwan Liposome Co., Ltd.
Taiwan Province, China
Patent: 6
Akebia Therapeutics, Inc.
Massachusetts, United States
Patent: 5
Veran Medical Technologies, Inc.
Missouri, United States
Patent: 5
TLC Biopharmaceuticals, Inc.
California, United States
Patent: 4
PerkinElmer Health Sciences, Inc.
Massachusetts, United States
Patent: 4
The First Affiliated Hospital of Zhengzhou University
Henan Sheng, China
Patent: 4
With the analysis among 1,152 patents, we discovered top 163 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, Boston University, Université Laval are dominant in this area. They take 13.45% of the total patent filing.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 53
Massachusetts, United States
Patent: 37
New York, United States
Patent: 24
The Johns Hopkins University
Connecticut, United States
Patent: 21
Tennessee, United States
Patent: 21
The University of Chicago
Illinois, United States
Patent: 15
Regents of the University of Colorado
Colorado, United States
Patent: 15
North Carolina, United States
Patent: 14